Current role of statins in the treatment of essential hypertension

被引:16
作者
Kostapanos, Michael S. [1 ]
Milionis, Haralampos J. [1 ]
Elisaf, Moses S. [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
关键词
blood pressure lowering; hyperlipidemia; hypertension; statin; COA REDUCTASE INHIBITORS; CORONARY-HEART-DISEASE; BLOOD-PRESSURE CONTROL; CHOLESTEROL-LOWERING TREATMENT; CONVERTING ENZYME-INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; LOW-DENSITY-LIPOPROTEIN; CARDIAC OUTCOMES TRIAL; PULSE-WAVE VELOCITY; LONG-TERM TREATMENT;
D O I
10.1517/14656566.2010.491512
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Importance of the field: Hypertension and hyperlipidemia often co-exist and seem to be interrelated through common pathophysiological pathways. Drugs employing beneficial effects in both conditions could be advantageous in a concerted effective management of patients at high cardiovascular risk. Statins are known to enhance cardiovascular protection beyond their lipid-lowering capacity. Areas covered in this review: MEDLINE was searched, up to January 2010, for studies assessing the effect of statin treatment on blood pressure control in various populations or animal models of hypertension. The potential mechanisms implicated in the putative antihypertensive action of statins are also reviewed. What the reader will gain: To learn about the role of statins as potential antihypertensive drugs in various populations. Clinical advice for the use of statins either as monotherapy or in combination with antihypertensive drugs in high-risk populations is also provided. Take home message: Statins may exert a mild, but clinically relevant, antihypertensive effect which is probably mediated by mechanisms that are independent of their lipid-lowering effects. Patients with high BP levels at baseline as well as those treated with ACE inhibitors and calcium channel blockers are expected to benefit more in this regard.
引用
收藏
页码:2635 / 2650
页数:16
相关论文
共 91 条
[1]  
Abetel G, 1998, SCHWEIZ MED WSCHR, V128, P272
[2]  
[Anonymous], 2002, JAMA, V288, P2998
[3]  
ANTONICELLI R, 1990, CLIN THER, V12, P165
[4]   Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: Clinical implications [J].
Asmar R. .
American Journal of Cardiovascular Drugs, 2001, 1 (5) :387-397
[5]   Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease [J].
Athyros, VG ;
Mikhailidis, DP ;
Papageorgiou, AA ;
Bouloukos, VI ;
Pehlivanidis, AN ;
Symeonidis, AN ;
Elisaf, M .
JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (11) :781-788
[6]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[7]  
Banach M, 2009, MED SCI MONITOR, V15, pMS1
[8]   Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study [J].
Borghi, C ;
Dormi, A ;
Veronesi, M ;
Sangiorgi, Z ;
Gaddi, A .
AMERICAN HEART JOURNAL, 2004, 148 (02) :285-292
[9]   Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia [J].
Borghi, C ;
Prandin, MG ;
Costa, FV ;
Bacchelli, S ;
Degli Esposti, D ;
Ambrosioni, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (04) :549-555
[10]   Mechanism of differential effects of antihypertensive agents on serum lipids [J].
Brook R.D. .
Current Hypertension Reports, 2000, 2 (4) :370-377